Invex Therapeutics Ltd.
做多
已更新

IXC - Invex Therapeutics

96
This company is a Phase 3 ORPHAN bio focusing in on IIH.
They have 31 mill cash on hand which will fully fund them all the way. They are currently valued at 40 mill MC so essentially 9 mill EV which is ridiculous for a Phase 3 bio.
Putting in a bottoming pattern now with a reverse head and shoulders developing.

A break of 80 cents will be the trigger point, at the moment its just in accumulation phase still
注释
So far so good, looks to have hit a bottom and now reversing creating that head

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。